Detalles de la búsqueda
1.
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
Lancet Oncol
; 23(9): 1156-1166, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35934010
2.
Lag3: From Bench to Bedside.
Cancer Treat Res
; 183: 185-199, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551660
3.
The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis.
Support Care Cancer
; 28(4): 1755-1764, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31302766
4.
Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.
Future Oncol
; 12(23): 2755-2764, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27549331
5.
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers.
Cell Rep Med
; 4(12): 101332, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38118420
6.
The immune landscape of undifferentiated pleomorphic sarcoma.
Front Oncol
; 12: 1008484, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36313661
7.
Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.
Sci Rep
; 11(1): 4530, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33633208
8.
Hypotensive activity of terpenes found in essential oils.
Z Naturforsch C J Biosci
; 65(9-10): 562-6, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21138056
9.
In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments.
Value Health Reg Issues
; 20: 47-50, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30856543
10.
Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study.
Sao Paulo Med J
; 137(6): 505-511, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32159636
11.
Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.
Einstein (Sao Paulo)
; 17(2): eGS4414, 2019 Mar 07.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-30843996
12.
A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors.
Drugs Context
; 7: 212555, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30416529
13.
Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.
Einstein (Sao Paulo)
; 15(3): 349-354, 2017.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-29091159
14.
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets.
ESMO Open
; 2(3): e000200, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29209522
15.
Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study
São Paulo med. j
; 137(6): 505-511, Nov.-Dec. 2019. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-1094519
16.
Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer / Análise de custo-efetividade da adição de abiraterona ou quimioterapia ao tratamento do câncer de próstata metastático hormônio-sensível
Einstein (Säo Paulo)
; 17(2): eGS4414, 2019. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-989781
17.
Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer / Custo-efetividade da adição de quimioterapia ao tratamento hormonal do câncer de próstata metastático sensível a hormônio ou localizado de alto risco
Einstein (Säo Paulo)
; 15(3): 349-354, July-Sept. 2017. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-891394
18.
[Geographical distribution of leptospirosis in Aracaju, State of Sergipe from 2001 to 2007]. / Espacialização da leptospirose em Aracaju, Estado de Sergipe, no período de 2001 a 2007.
Rev Soc Bras Med Trop
; 44(4): 475-80, 2011.
Artículo
en Portugués
| MEDLINE | ID: mdl-21860894
19.
Espacialização da leptospirose em Aracaju, Estado de Sergipe, no período de 2001 a 2007 / Geographical distribution of leptospirosis in Aracaju, State of Sergipe from 2001 to 2007
Rev. Soc. Bras. Med. Trop
; 44(4): 475-480, July-Aug. 2011. ilus
Artículo
en Portugués
| LILACS | ID: lil-596597
20.
Espacialização da leptospirose em Aracaju, Estado de Sergipe, no período de 2001 a 2007 / Geographical distribution of leptospirosis in Aracaju, State of Sergipe from 2001 to 2007
Rev. Soc. Bras. Med. Trop
; 44(4): 475-480, jul.-ago. 2011. mapas
Artículo
en Portugués
| BVSDIP, FIOCRUZ | ID: dip-3174